Key Insights
The Organs-on-Chips (OoC) market is experiencing robust growth, projected to reach a significant size driven by increasing demand for advanced drug discovery and toxicology research tools. The market's Compound Annual Growth Rate (CAGR) of 30.94% from 2019 to 2024 indicates substantial market expansion. This rapid growth is fueled by several key factors. The pharmaceutical and biotechnology industries are increasingly adopting OoC technology to reduce reliance on animal testing, accelerate drug development timelines, and improve the accuracy of preclinical studies. Academic and research institutions are also significant contributors to market growth, leveraging OoC platforms for fundamental biological research and disease modeling. Specific organ types such as liver, heart, and lung models are currently driving market demand, offering high-fidelity representations of human physiology for diverse applications. However, the market faces certain challenges. High initial investment costs for OoC systems and the complexity associated with operating and maintaining these sophisticated platforms can present barriers to entry for some potential users. Furthermore, regulatory approval pathways for data generated from OoC models are still evolving, creating uncertainty for some researchers and companies.
Organs-on-Chips Industry Market Size (In Million)
Despite these restraints, the long-term outlook for the OoC market remains highly positive. Continued technological advancements, including the development of more sophisticated and user-friendly OoC devices, coupled with decreasing costs and increased regulatory clarity, are expected to further propel market expansion. The emergence of multi-organ chip platforms and advanced bioprinting techniques will broaden the applications of OoC technology, leading to wider adoption across various research and development sectors. The market segmentation, with key players like Elveflow, Emulate Inc., and MIMETAS BV, shows a competitive landscape with ample opportunities for innovation and expansion in both established and emerging markets, notably in North America and Asia Pacific regions which are expected to lead market penetration given the existing robust research infrastructure and pharmaceutical industry. The market's trajectory strongly suggests continued growth, presenting significant opportunities for investors and innovators alike.
Organs-on-Chips Industry Company Market Share
Organs-on-Chips Industry Market Report: 2019-2033
This comprehensive report provides an in-depth analysis of the Organs-on-Chips industry, projecting a market valuation exceeding $XX Million by 2033. The study covers the historical period (2019-2024), base year (2025), and forecast period (2025-2033), offering invaluable insights for stakeholders across the pharmaceutical, biotechnology, and research sectors. This report is crucial for understanding market dynamics, identifying key players, and capitalizing on future opportunities in this rapidly evolving field.
Organs-on-Chips Industry Market Composition & Trends
The Organs-on-Chips market is experiencing significant growth driven by advancements in microfluidics, 3D cell culture, and the increasing need for human-relevant in vitro models. Market concentration is moderate, with several key players vying for market share. The industry is characterized by continuous innovation, fueled by substantial investments in research and development. Regulatory landscapes vary across regions, influencing adoption rates and market access. Substitute products, like traditional animal models, still hold a significant presence but are gradually being replaced due to limitations in translational efficacy. The industry is witnessing a wave of mergers and acquisitions (M&A) activity, as larger players consolidate their market positions and expand their product portfolios. Deal values in recent years have reached hundreds of Millions of dollars.
- Market Share Distribution (2025): Emulate Inc: 15%, MIMETAS BV: 10%, Other players: 75% (this is an estimation).
- M&A Activity (2019-2024): Total deal value exceeding $XX Million. Key acquisitions included Valo Health's acquisition of Tara Biosystems.
Organs-on-Chips Industry Industry Evolution
The Organs-on-Chips market has witnessed remarkable growth since 2019, expanding from a value of $XX Million to an estimated $XX Million in 2025. This growth is projected to continue at a CAGR of XX% during the forecast period (2025-2033). Technological advancements, such as improvements in microfluidic device fabrication and biomaterial development, have played a crucial role in driving market expansion. Growing concerns about animal welfare and the limitations of traditional in vitro models are further propelling the adoption of Organs-on-Chips technology. The demand for more accurate and predictive models in drug discovery and toxicology research fuels the market's growth. Adoption metrics show a steady increase in the utilization of Organs-on-Chips across various research settings and applications. The market is also witnessing a shift towards sophisticated, integrated systems combining multiple organ chips to mimic complex physiological processes.
Leading Regions, Countries, or Segments in Organs-on-Chips Industry
North America currently dominates the Organs-on-Chips market, driven by significant investments in research and development, coupled with the presence of key players and supportive regulatory frameworks. Europe follows closely, with a strong academic research base and a growing pharmaceutical and biotechnology industry.
Key Drivers:
- High Research Funding: Significant government and private investments in biomedical research.
- Stringent Regulations: Increased regulatory pressure for improved animal welfare and human-relevant testing methods.
- Strong Pharmaceutical & Biotech Industry: A large pool of potential end-users focusing on accelerated drug development and reduced pre-clinical costs.
Dominance Factors (North America): High concentration of leading companies, robust funding ecosystem, and strong regulatory support for innovative drug development technologies. The U.S. specifically benefits from a strong FDA partnership and considerable government-backed funding initiatives.
Application Segmentation: Drug Discovery is the leading segment, followed by Toxicology Research. Other applications, including disease modeling and personalized medicine, are demonstrating increasing growth potential.
End-User Segmentation: Pharmaceutical and Biotechnology companies remain the largest end-users, closely followed by academic and research institutes.
Organ Type Segmentation: Liver and Heart organ-on-a-chip models presently lead the market due to their wide applications in drug discovery and toxicity testing.
Organs-on-Chips Industry Product Innovations
Recent innovations have focused on enhancing the biomimicry and scalability of Organs-on-Chips. Advancements include the integration of advanced sensors and imaging techniques for real-time monitoring, improved cell culture protocols for increased physiological relevance, and the development of more sophisticated microfluidic designs mimicking physiological flows and gradients. This facilitates high-throughput screening, leading to increased efficiency in drug discovery and personalized medicine studies. These innovative developments offer unique selling propositions through improved accuracy, reduced costs, and enhanced speed in research.
Propelling Factors for Organs-on-Chips Industry Growth
Technological advancements in microfluidics, biomaterials, and cell culture technologies are key growth drivers. The rising demand for improved drug discovery models, coupled with increasing awareness of the limitations of animal models, further propels market growth. Favorable regulatory landscapes in certain regions, supporting the adoption of innovative technologies, also contribute significantly. For example, the FDA’s acceptance of Organs-on-Chips data in regulatory submissions is driving industry uptake.
Obstacles in the Organs-on-Chips Industry Market
High initial costs associated with developing and implementing Organs-on-Chips technologies remain a barrier for widespread adoption, especially for smaller research institutions. Supply chain disruptions affecting specialized components and consumables can create bottlenecks. Intense competition among existing and emerging players presents a challenge for market penetration. Additionally, the standardization of protocols and data analysis across different platforms remains a crucial need. These factors collectively impede the rapid expansion of the market. The impact of these issues can be quantified by slower growth rates compared to predictions in certain regions.
Future Opportunities in Organs-on-Chips Industry
Emerging opportunities include the development of more complex, multi-organ systems that can better mimic human physiology, further enhancing the predictive capabilities of these platforms. The integration of artificial intelligence (AI) and machine learning for data analysis will further revolutionize research capabilities. Expanding applications in personalized medicine and disease modeling offer immense growth potential. New markets in developing countries with rising healthcare spending will create further avenues for expansion.
Major Players in the Organs-on-Chips Industry Ecosystem
- Elveflow
- Emulate Inc
- Bi/ond
- AxoSim
- Hesperos
- MIMETAS BV
- Altis Biosystems
- BiomimX SRL
- Valo Health (Tara Biosystems Inc)
- Netri
- Nortis Inc
- TissUse GmbH
- Allevi Inc
- InSphero
Key Developments in Organs-on-Chips Industry Industry
- April 2022: Valo Health acquired TARA Biosystems, expanding its capabilities in cardiovascular disease modeling and drug development. This deal significantly impacted market dynamics, consolidating a major player's position and influencing future development strategies within the sector.
- May 2022: Emulate upgraded its intestinal organ-on-a-chip, enhancing its application in inflammatory bowel disease research. This product launch improved the market offering and stimulated further research in this vital area of medicine.
Strategic Organs-on-Chips Industry Market Forecast
The Organs-on-Chips market is poised for substantial growth, driven by technological advancements, increasing adoption across research and pharmaceutical sectors, and a favorable regulatory environment. The market's future is bright, with expanding applications in personalized medicine, disease modeling, and high-throughput drug screening offering immense growth potential. The ongoing integration of AI and advanced analytical tools will further accelerate market expansion. Significant opportunities exist for players developing innovative products and services that enhance the accuracy, efficiency, and scalability of Organs-on-Chips technologies.
Organs-on-Chips Industry Segmentation
-
1. Organ Type
- 1.1. Liver
- 1.2. Heart
- 1.3. Lung
- 1.4. Other Organ Types
-
2. Application
- 2.1. Drug Discovery
- 2.2. Toxicology Research
- 2.3. Other Applications
-
3. End User
- 3.1. Pharmaceutical and Biotechnology Companies
- 3.2. Academic and Research Institutes
- 3.3. Other End Users
Organs-on-Chips Industry Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
- 4. Rest of the World
Organs-on-Chips Industry Regional Market Share
Geographic Coverage of Organs-on-Chips Industry
Organs-on-Chips Industry REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 30.94% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Requirement of Alternative for Animal Testing; Need for Early Detection of Drug Toxicity and New Products Launches
- 3.3. Market Restrains
- 3.3.1. Complexity of Organ-on-chip Models
- 3.4. Market Trends
- 3.4.1. Lung-related Application is Expected to Exhibit a Significant Growth Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Organs-on-Chips Industry Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Organ Type
- 5.1.1. Liver
- 5.1.2. Heart
- 5.1.3. Lung
- 5.1.4. Other Organ Types
- 5.2. Market Analysis, Insights and Forecast - by Application
- 5.2.1. Drug Discovery
- 5.2.2. Toxicology Research
- 5.2.3. Other Applications
- 5.3. Market Analysis, Insights and Forecast - by End User
- 5.3.1. Pharmaceutical and Biotechnology Companies
- 5.3.2. Academic and Research Institutes
- 5.3.3. Other End Users
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Rest of the World
- 5.1. Market Analysis, Insights and Forecast - by Organ Type
- 6. North America Organs-on-Chips Industry Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Organ Type
- 6.1.1. Liver
- 6.1.2. Heart
- 6.1.3. Lung
- 6.1.4. Other Organ Types
- 6.2. Market Analysis, Insights and Forecast - by Application
- 6.2.1. Drug Discovery
- 6.2.2. Toxicology Research
- 6.2.3. Other Applications
- 6.3. Market Analysis, Insights and Forecast - by End User
- 6.3.1. Pharmaceutical and Biotechnology Companies
- 6.3.2. Academic and Research Institutes
- 6.3.3. Other End Users
- 6.1. Market Analysis, Insights and Forecast - by Organ Type
- 7. Europe Organs-on-Chips Industry Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Organ Type
- 7.1.1. Liver
- 7.1.2. Heart
- 7.1.3. Lung
- 7.1.4. Other Organ Types
- 7.2. Market Analysis, Insights and Forecast - by Application
- 7.2.1. Drug Discovery
- 7.2.2. Toxicology Research
- 7.2.3. Other Applications
- 7.3. Market Analysis, Insights and Forecast - by End User
- 7.3.1. Pharmaceutical and Biotechnology Companies
- 7.3.2. Academic and Research Institutes
- 7.3.3. Other End Users
- 7.1. Market Analysis, Insights and Forecast - by Organ Type
- 8. Asia Pacific Organs-on-Chips Industry Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Organ Type
- 8.1.1. Liver
- 8.1.2. Heart
- 8.1.3. Lung
- 8.1.4. Other Organ Types
- 8.2. Market Analysis, Insights and Forecast - by Application
- 8.2.1. Drug Discovery
- 8.2.2. Toxicology Research
- 8.2.3. Other Applications
- 8.3. Market Analysis, Insights and Forecast - by End User
- 8.3.1. Pharmaceutical and Biotechnology Companies
- 8.3.2. Academic and Research Institutes
- 8.3.3. Other End Users
- 8.1. Market Analysis, Insights and Forecast - by Organ Type
- 9. Rest of the World Organs-on-Chips Industry Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Organ Type
- 9.1.1. Liver
- 9.1.2. Heart
- 9.1.3. Lung
- 9.1.4. Other Organ Types
- 9.2. Market Analysis, Insights and Forecast - by Application
- 9.2.1. Drug Discovery
- 9.2.2. Toxicology Research
- 9.2.3. Other Applications
- 9.3. Market Analysis, Insights and Forecast - by End User
- 9.3.1. Pharmaceutical and Biotechnology Companies
- 9.3.2. Academic and Research Institutes
- 9.3.3. Other End Users
- 9.1. Market Analysis, Insights and Forecast - by Organ Type
- 10. Competitive Analysis
- 10.1. Global Market Share Analysis 2025
- 10.2. Company Profiles
- 10.2.1 Elveflow
- 10.2.1.1. Overview
- 10.2.1.2. Products
- 10.2.1.3. SWOT Analysis
- 10.2.1.4. Recent Developments
- 10.2.1.5. Financials (Based on Availability)
- 10.2.2 Emulate Inc
- 10.2.2.1. Overview
- 10.2.2.2. Products
- 10.2.2.3. SWOT Analysis
- 10.2.2.4. Recent Developments
- 10.2.2.5. Financials (Based on Availability)
- 10.2.3 Bi/ond
- 10.2.3.1. Overview
- 10.2.3.2. Products
- 10.2.3.3. SWOT Analysis
- 10.2.3.4. Recent Developments
- 10.2.3.5. Financials (Based on Availability)
- 10.2.4 AxoSim
- 10.2.4.1. Overview
- 10.2.4.2. Products
- 10.2.4.3. SWOT Analysis
- 10.2.4.4. Recent Developments
- 10.2.4.5. Financials (Based on Availability)
- 10.2.5 Hesperos
- 10.2.5.1. Overview
- 10.2.5.2. Products
- 10.2.5.3. SWOT Analysis
- 10.2.5.4. Recent Developments
- 10.2.5.5. Financials (Based on Availability)
- 10.2.6 MIMETAS BV
- 10.2.6.1. Overview
- 10.2.6.2. Products
- 10.2.6.3. SWOT Analysis
- 10.2.6.4. Recent Developments
- 10.2.6.5. Financials (Based on Availability)
- 10.2.7 Altis Biosystems
- 10.2.7.1. Overview
- 10.2.7.2. Products
- 10.2.7.3. SWOT Analysis
- 10.2.7.4. Recent Developments
- 10.2.7.5. Financials (Based on Availability)
- 10.2.8 BiomimX SRL
- 10.2.8.1. Overview
- 10.2.8.2. Products
- 10.2.8.3. SWOT Analysis
- 10.2.8.4. Recent Developments
- 10.2.8.5. Financials (Based on Availability)
- 10.2.9 Valo Health (Tara Biosystems Inc )
- 10.2.9.1. Overview
- 10.2.9.2. Products
- 10.2.9.3. SWOT Analysis
- 10.2.9.4. Recent Developments
- 10.2.9.5. Financials (Based on Availability)
- 10.2.10 Netri
- 10.2.10.1. Overview
- 10.2.10.2. Products
- 10.2.10.3. SWOT Analysis
- 10.2.10.4. Recent Developments
- 10.2.10.5. Financials (Based on Availability)
- 10.2.11 Nortis Inc
- 10.2.11.1. Overview
- 10.2.11.2. Products
- 10.2.11.3. SWOT Analysis
- 10.2.11.4. Recent Developments
- 10.2.11.5. Financials (Based on Availability)
- 10.2.12 TissUse GmbH
- 10.2.12.1. Overview
- 10.2.12.2. Products
- 10.2.12.3. SWOT Analysis
- 10.2.12.4. Recent Developments
- 10.2.12.5. Financials (Based on Availability)
- 10.2.13 Allevi Inc
- 10.2.13.1. Overview
- 10.2.13.2. Products
- 10.2.13.3. SWOT Analysis
- 10.2.13.4. Recent Developments
- 10.2.13.5. Financials (Based on Availability)
- 10.2.14 InSphero
- 10.2.14.1. Overview
- 10.2.14.2. Products
- 10.2.14.3. SWOT Analysis
- 10.2.14.4. Recent Developments
- 10.2.14.5. Financials (Based on Availability)
- 10.2.1 Elveflow
List of Figures
- Figure 1: Global Organs-on-Chips Industry Revenue Breakdown (Million, %) by Region 2025 & 2033
- Figure 2: Global Organs-on-Chips Industry Volume Breakdown (K Unit, %) by Region 2025 & 2033
- Figure 3: North America Organs-on-Chips Industry Revenue (Million), by Organ Type 2025 & 2033
- Figure 4: North America Organs-on-Chips Industry Volume (K Unit), by Organ Type 2025 & 2033
- Figure 5: North America Organs-on-Chips Industry Revenue Share (%), by Organ Type 2025 & 2033
- Figure 6: North America Organs-on-Chips Industry Volume Share (%), by Organ Type 2025 & 2033
- Figure 7: North America Organs-on-Chips Industry Revenue (Million), by Application 2025 & 2033
- Figure 8: North America Organs-on-Chips Industry Volume (K Unit), by Application 2025 & 2033
- Figure 9: North America Organs-on-Chips Industry Revenue Share (%), by Application 2025 & 2033
- Figure 10: North America Organs-on-Chips Industry Volume Share (%), by Application 2025 & 2033
- Figure 11: North America Organs-on-Chips Industry Revenue (Million), by End User 2025 & 2033
- Figure 12: North America Organs-on-Chips Industry Volume (K Unit), by End User 2025 & 2033
- Figure 13: North America Organs-on-Chips Industry Revenue Share (%), by End User 2025 & 2033
- Figure 14: North America Organs-on-Chips Industry Volume Share (%), by End User 2025 & 2033
- Figure 15: North America Organs-on-Chips Industry Revenue (Million), by Country 2025 & 2033
- Figure 16: North America Organs-on-Chips Industry Volume (K Unit), by Country 2025 & 2033
- Figure 17: North America Organs-on-Chips Industry Revenue Share (%), by Country 2025 & 2033
- Figure 18: North America Organs-on-Chips Industry Volume Share (%), by Country 2025 & 2033
- Figure 19: Europe Organs-on-Chips Industry Revenue (Million), by Organ Type 2025 & 2033
- Figure 20: Europe Organs-on-Chips Industry Volume (K Unit), by Organ Type 2025 & 2033
- Figure 21: Europe Organs-on-Chips Industry Revenue Share (%), by Organ Type 2025 & 2033
- Figure 22: Europe Organs-on-Chips Industry Volume Share (%), by Organ Type 2025 & 2033
- Figure 23: Europe Organs-on-Chips Industry Revenue (Million), by Application 2025 & 2033
- Figure 24: Europe Organs-on-Chips Industry Volume (K Unit), by Application 2025 & 2033
- Figure 25: Europe Organs-on-Chips Industry Revenue Share (%), by Application 2025 & 2033
- Figure 26: Europe Organs-on-Chips Industry Volume Share (%), by Application 2025 & 2033
- Figure 27: Europe Organs-on-Chips Industry Revenue (Million), by End User 2025 & 2033
- Figure 28: Europe Organs-on-Chips Industry Volume (K Unit), by End User 2025 & 2033
- Figure 29: Europe Organs-on-Chips Industry Revenue Share (%), by End User 2025 & 2033
- Figure 30: Europe Organs-on-Chips Industry Volume Share (%), by End User 2025 & 2033
- Figure 31: Europe Organs-on-Chips Industry Revenue (Million), by Country 2025 & 2033
- Figure 32: Europe Organs-on-Chips Industry Volume (K Unit), by Country 2025 & 2033
- Figure 33: Europe Organs-on-Chips Industry Revenue Share (%), by Country 2025 & 2033
- Figure 34: Europe Organs-on-Chips Industry Volume Share (%), by Country 2025 & 2033
- Figure 35: Asia Pacific Organs-on-Chips Industry Revenue (Million), by Organ Type 2025 & 2033
- Figure 36: Asia Pacific Organs-on-Chips Industry Volume (K Unit), by Organ Type 2025 & 2033
- Figure 37: Asia Pacific Organs-on-Chips Industry Revenue Share (%), by Organ Type 2025 & 2033
- Figure 38: Asia Pacific Organs-on-Chips Industry Volume Share (%), by Organ Type 2025 & 2033
- Figure 39: Asia Pacific Organs-on-Chips Industry Revenue (Million), by Application 2025 & 2033
- Figure 40: Asia Pacific Organs-on-Chips Industry Volume (K Unit), by Application 2025 & 2033
- Figure 41: Asia Pacific Organs-on-Chips Industry Revenue Share (%), by Application 2025 & 2033
- Figure 42: Asia Pacific Organs-on-Chips Industry Volume Share (%), by Application 2025 & 2033
- Figure 43: Asia Pacific Organs-on-Chips Industry Revenue (Million), by End User 2025 & 2033
- Figure 44: Asia Pacific Organs-on-Chips Industry Volume (K Unit), by End User 2025 & 2033
- Figure 45: Asia Pacific Organs-on-Chips Industry Revenue Share (%), by End User 2025 & 2033
- Figure 46: Asia Pacific Organs-on-Chips Industry Volume Share (%), by End User 2025 & 2033
- Figure 47: Asia Pacific Organs-on-Chips Industry Revenue (Million), by Country 2025 & 2033
- Figure 48: Asia Pacific Organs-on-Chips Industry Volume (K Unit), by Country 2025 & 2033
- Figure 49: Asia Pacific Organs-on-Chips Industry Revenue Share (%), by Country 2025 & 2033
- Figure 50: Asia Pacific Organs-on-Chips Industry Volume Share (%), by Country 2025 & 2033
- Figure 51: Rest of the World Organs-on-Chips Industry Revenue (Million), by Organ Type 2025 & 2033
- Figure 52: Rest of the World Organs-on-Chips Industry Volume (K Unit), by Organ Type 2025 & 2033
- Figure 53: Rest of the World Organs-on-Chips Industry Revenue Share (%), by Organ Type 2025 & 2033
- Figure 54: Rest of the World Organs-on-Chips Industry Volume Share (%), by Organ Type 2025 & 2033
- Figure 55: Rest of the World Organs-on-Chips Industry Revenue (Million), by Application 2025 & 2033
- Figure 56: Rest of the World Organs-on-Chips Industry Volume (K Unit), by Application 2025 & 2033
- Figure 57: Rest of the World Organs-on-Chips Industry Revenue Share (%), by Application 2025 & 2033
- Figure 58: Rest of the World Organs-on-Chips Industry Volume Share (%), by Application 2025 & 2033
- Figure 59: Rest of the World Organs-on-Chips Industry Revenue (Million), by End User 2025 & 2033
- Figure 60: Rest of the World Organs-on-Chips Industry Volume (K Unit), by End User 2025 & 2033
- Figure 61: Rest of the World Organs-on-Chips Industry Revenue Share (%), by End User 2025 & 2033
- Figure 62: Rest of the World Organs-on-Chips Industry Volume Share (%), by End User 2025 & 2033
- Figure 63: Rest of the World Organs-on-Chips Industry Revenue (Million), by Country 2025 & 2033
- Figure 64: Rest of the World Organs-on-Chips Industry Volume (K Unit), by Country 2025 & 2033
- Figure 65: Rest of the World Organs-on-Chips Industry Revenue Share (%), by Country 2025 & 2033
- Figure 66: Rest of the World Organs-on-Chips Industry Volume Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Organs-on-Chips Industry Revenue Million Forecast, by Organ Type 2020 & 2033
- Table 2: Global Organs-on-Chips Industry Volume K Unit Forecast, by Organ Type 2020 & 2033
- Table 3: Global Organs-on-Chips Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 4: Global Organs-on-Chips Industry Volume K Unit Forecast, by Application 2020 & 2033
- Table 5: Global Organs-on-Chips Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 6: Global Organs-on-Chips Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 7: Global Organs-on-Chips Industry Revenue Million Forecast, by Region 2020 & 2033
- Table 8: Global Organs-on-Chips Industry Volume K Unit Forecast, by Region 2020 & 2033
- Table 9: Global Organs-on-Chips Industry Revenue Million Forecast, by Organ Type 2020 & 2033
- Table 10: Global Organs-on-Chips Industry Volume K Unit Forecast, by Organ Type 2020 & 2033
- Table 11: Global Organs-on-Chips Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 12: Global Organs-on-Chips Industry Volume K Unit Forecast, by Application 2020 & 2033
- Table 13: Global Organs-on-Chips Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 14: Global Organs-on-Chips Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 15: Global Organs-on-Chips Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 16: Global Organs-on-Chips Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 17: United States Organs-on-Chips Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 18: United States Organs-on-Chips Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 19: Canada Organs-on-Chips Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 20: Canada Organs-on-Chips Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 21: Mexico Organs-on-Chips Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 22: Mexico Organs-on-Chips Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 23: Global Organs-on-Chips Industry Revenue Million Forecast, by Organ Type 2020 & 2033
- Table 24: Global Organs-on-Chips Industry Volume K Unit Forecast, by Organ Type 2020 & 2033
- Table 25: Global Organs-on-Chips Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 26: Global Organs-on-Chips Industry Volume K Unit Forecast, by Application 2020 & 2033
- Table 27: Global Organs-on-Chips Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 28: Global Organs-on-Chips Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 29: Global Organs-on-Chips Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 30: Global Organs-on-Chips Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 31: Germany Organs-on-Chips Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 32: Germany Organs-on-Chips Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 33: United Kingdom Organs-on-Chips Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 34: United Kingdom Organs-on-Chips Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 35: France Organs-on-Chips Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 36: France Organs-on-Chips Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 37: Italy Organs-on-Chips Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 38: Italy Organs-on-Chips Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 39: Spain Organs-on-Chips Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 40: Spain Organs-on-Chips Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 41: Rest of Europe Organs-on-Chips Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 42: Rest of Europe Organs-on-Chips Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 43: Global Organs-on-Chips Industry Revenue Million Forecast, by Organ Type 2020 & 2033
- Table 44: Global Organs-on-Chips Industry Volume K Unit Forecast, by Organ Type 2020 & 2033
- Table 45: Global Organs-on-Chips Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 46: Global Organs-on-Chips Industry Volume K Unit Forecast, by Application 2020 & 2033
- Table 47: Global Organs-on-Chips Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 48: Global Organs-on-Chips Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 49: Global Organs-on-Chips Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 50: Global Organs-on-Chips Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 51: China Organs-on-Chips Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 52: China Organs-on-Chips Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 53: Japan Organs-on-Chips Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 54: Japan Organs-on-Chips Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 55: India Organs-on-Chips Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 56: India Organs-on-Chips Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 57: Australia Organs-on-Chips Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 58: Australia Organs-on-Chips Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 59: South Korea Organs-on-Chips Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 60: South Korea Organs-on-Chips Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 61: Rest of Asia Pacific Organs-on-Chips Industry Revenue (Million) Forecast, by Application 2020 & 2033
- Table 62: Rest of Asia Pacific Organs-on-Chips Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 63: Global Organs-on-Chips Industry Revenue Million Forecast, by Organ Type 2020 & 2033
- Table 64: Global Organs-on-Chips Industry Volume K Unit Forecast, by Organ Type 2020 & 2033
- Table 65: Global Organs-on-Chips Industry Revenue Million Forecast, by Application 2020 & 2033
- Table 66: Global Organs-on-Chips Industry Volume K Unit Forecast, by Application 2020 & 2033
- Table 67: Global Organs-on-Chips Industry Revenue Million Forecast, by End User 2020 & 2033
- Table 68: Global Organs-on-Chips Industry Volume K Unit Forecast, by End User 2020 & 2033
- Table 69: Global Organs-on-Chips Industry Revenue Million Forecast, by Country 2020 & 2033
- Table 70: Global Organs-on-Chips Industry Volume K Unit Forecast, by Country 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Organs-on-Chips Industry?
The projected CAGR is approximately 30.94%.
2. Which companies are prominent players in the Organs-on-Chips Industry?
Key companies in the market include Elveflow, Emulate Inc, Bi/ond, AxoSim, Hesperos, MIMETAS BV, Altis Biosystems, BiomimX SRL, Valo Health (Tara Biosystems Inc ), Netri, Nortis Inc, TissUse GmbH, Allevi Inc, InSphero.
3. What are the main segments of the Organs-on-Chips Industry?
The market segments include Organ Type, Application, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 0.3 Million as of 2022.
5. What are some drivers contributing to market growth?
Requirement of Alternative for Animal Testing; Need for Early Detection of Drug Toxicity and New Products Launches.
6. What are the notable trends driving market growth?
Lung-related Application is Expected to Exhibit a Significant Growth Over the Forecast Period.
7. Are there any restraints impacting market growth?
Complexity of Organ-on-chip Models.
8. Can you provide examples of recent developments in the market?
May 2022 : Emulate upgraded its intestinal organ-on-a-chip for researchers studying inflammatory bowel disease.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Organs-on-Chips Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Organs-on-Chips Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Organs-on-Chips Industry?
To stay informed about further developments, trends, and reports in the Organs-on-Chips Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence